Pharmacokinetics and pharmacodynamics: Difference between revisions
From IDWiki
(Created page with "{| class="wikitable" !Antimicrobial !Bactericidal Pattern !PK-PD Measure |- |aminoglycosides |concentration-dependent |AUC<sub>0-24</sub>:MIC, C<sub>max</sub>:MIC |- |β...") |
No edit summary |
||
Line 1: | Line 1: | ||
== Background == |
|||
* '''Pharmacokinetics''' refers to the movement of drug through the body, and is characterized by absorption, distribution, metabolism, and excretion |
|||
* '''Pharmacodynamics''' refers to the effect of the drug on the body |
|||
== Antimicrobials == |
|||
{| class="wikitable" |
{| class="wikitable" |
||
!Antimicrobial |
!Antimicrobial |
||
Line 53: | Line 59: | ||
|} |
|} |
||
== |
==Further Reading== |
||
* |
*Pharmacokinetics-Pharmacodynamics of Antimicrobial Therapy: It's Not Just for Mice Anymore. ''Clin Infect Dis''. 2007;44(1):79-86. doi: [https://doi.org/10.1086/510079 10.1086/510079] |
Latest revision as of 21:34, 5 March 2021
Background
- Pharmacokinetics refers to the movement of drug through the body, and is characterized by absorption, distribution, metabolism, and excretion
- Pharmacodynamics refers to the effect of the drug on the body
Antimicrobials
Antimicrobial | Bactericidal Pattern | PK-PD Measure |
---|---|---|
aminoglycosides | concentration-dependent | AUC0-24:MIC, Cmax:MIC |
β-lactams | time-dependent | T>MIC |
clindamycin | time-dependent | AUC0-24:MIC |
daptomycin | concentration-dependent | AUC0-24:MIC, Cmax:MIC |
vancomycin | time-dependent | AUC0-24:MIC |
azithromycin | time-dependent | AUC0-24:MIC |
clarithromycin | time-dependent | AUC0-24:MIC |
metronidazole | concentration-dependent | AUC0-24:MIC, Cmax:MIC |
linezolid | time-dependent | AUC0-24:MIC |
fluoroquinolones | concentration-dependent | AUC0-24:MIC, Cmax:MIC |
doxycycline | time-dependent | AUC0-24:MIC |
tigecycline | time-dependent | AUC0-24:MIC |
Further Reading
- Pharmacokinetics-Pharmacodynamics of Antimicrobial Therapy: It's Not Just for Mice Anymore. Clin Infect Dis. 2007;44(1):79-86. doi: 10.1086/510079